Propylthiouracil-induced Antineutrophil Cytoplasmic Antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: A comparative study

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 558-563

  Chen, Yong Xi ^a   Zhang, Wen ^a   Chen, Xiao Nong ^a   Yu, Hai Jin ^a   Ni, Li Yan ^a   Xu, Jing ^a   Pan, Xiao Xia ^a   Ren, Hong ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antineutrophil cytoplasmic antibodies; Propylthiouracil; Renal involvement; Vasculitis

Indexed keywords

CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANCA ASSOCIATED RENAL VASCULITIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; BIRMINGHAM VASCULITIS ASSESSMENT SCORE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RENOVASCULAR DISEASE; SCORING SYSTEM; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTITHYROID AGENTS; CREATININE; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID DISEASES; YOUNG ADULT;

EID: 84863274335     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110931     Document Type: Article

References (25)

1. Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: A systematic review. JAMA 2007;298:655-69. (Pubitemid 47236417)
2. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-18. (Pubitemid 44108124)
3. Nebesio TD, Eugster EA. Antithyroid drugs. N Engl J Med 2005;352:2246-7; author reply 7.
4. Chen YX, Yu HJ, Ni LY, Zhang W, Xu YW, Ren H, et al. Propylthiouracil- associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J Rheumatol 2007;34:2451-6. (Pubitemid 350230670)
5. Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am 2001;27:849-62. (Pubitemid 33054997)
6. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7. (Pubitemid 20273294)
7. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100. (Pubitemid 20273293)
8. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92. (Pubitemid 24065492)
9. Chen YX, Yu HJ, Zhang W, Ren H, Chen XN, Shen PY, et al. Analyzing fatal cases of Chinese patients with primary antineutrophil cytoplasmic antibodies-associated renal vasculitis: A 10-year retrospective study. Kidney Blood Press Res 2008;31:343-9.
10. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
11. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-92. (Pubitemid 46579626)
12. Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum 2005;53:108-13. (Pubitemid 40216359)
13. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney Int 2000;57:846-62. (Pubitemid 30434775)
14. Fujieda M, Hattori M, Kurayama H, Koitabashi Y. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 2002;13:437-45. (Pubitemid 34106286)
15. Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis 2007;49:607-14. (Pubitemid 46654487)
16. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology 2008;47:1515-20.
17. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 2003;41:776-84. (Pubitemid 36396745)
18. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century - A disease of older patients. Rheumatology 2005;44:495-501. (Pubitemid 41511141)
19. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994;266:810-3. (Pubitemid 24359291)
20. Slot MC LT, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum 2005;53:108-13. (Pubitemid 40216359)
21. Zhao MH, Chen M, Gao Y, Wang HY. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2006;69:1477-81.
22. Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int Immunopharmacol 2007;7:55-60. (Pubitemid 44856387)
23. Gao Y, Zhao MH, Guo XH, Xin G, Wang HY. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res 2004;30:205-13. (Pubitemid 39243121)
24. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006;17:2264-74. (Pubitemid 44141917)
25. Pavone L, Grasselli C, Chierici E, Maggiore U, Garini G, Ronda N, et al. Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol 2006;33:1299-306. (Pubitemid 44025144)